Aquestive(AQST)
Search documents
Aquestive(AQST) - 2021 Q2 - Earnings Call Transcript
2021-08-04 15:34
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q2 2021 Earnings Conference Call August 4, 2021 8:00 AM ET Company Participants Stephanie Carrington - IR Keith Kendall - President & CEO Ernie Toth - CFO Ken Marshall - SVP, CCO Dan Barber - COO Conference Call Participants Evan Seigerman - BMO Capital Markets Jason Butler - JMP Securities Daniel Busby - RBC Capital Markets Thomas Flaten - Lake Street Capital Andreas Argyrides - Wedbush Ram Selvaraju - H.C. Wainwright Operator Good day and thank you for standing b ...
Aquestive(AQST) - 2021 Q1 - Earnings Call Transcript
2021-05-05 15:13
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2021 Earnings Conference Call May 5, 2021 8:00 AM ET Company Participants Stephanie Carrington - IR Keith Kendall - President and CEO Ernie Toth - Interim CFO Daniel Barber - SVP and COO Conference Call Participants Gary Nachman - BMO Capital Markets Jason Butler - JMP Securities Shveta Dighe - Wedbush Thomas Flaten - Lake Street Capital Ram Selvaraju - H.C. Wainwright Operator Good morning and welcome to Aquestive Therapeutics First Quarter 2021 Conference Call ...
Aquestive(AQST) - 2020 Q4 - Earnings Call Transcript
2021-03-10 17:55
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2020 Earnings Conference Call March 10, 2021 8:00 AM ET Company Participants Stephanie Carrington - Investor Relations Keith Kendall - President and Chief Executive Officer Ernie Toth - Interim Chief Financial Officer Daniel Barber - Senior Vice President and Chief Operating Officer Conference Call Participants Gary Nachman - BMO Capital Markets Randall Stanicky - RBC Capital Markets Shveta Dighe - Wedbush Securities Jason Butler - JMP Securities Thomas Flaten - ...
Aquestive(AQST) - 2020 Q3 - Earnings Call Transcript
2020-11-08 10:12
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q3 2020 Results Earnings Conference Call November 5, 2020 8:00 AM ET Company Participants Stephanie Carrington - IR, Westwicke Keith Kendall - President and Chief Executive Officer John Maxwell - SVP and Chief Financial Officer Dan Barber - SVP and Chief Operating Officer Ken Marshall - SVP and Chief Commercial Officer Conference Call Participants Gary Nachman - BMO Capital Markets Andreas Argyrides - Wedbush Thomas Flaten - Lake Street Capital Operator Ladies and ...
Aquestive(AQST) - 2020 Q3 - Quarterly Report
2020-11-04 21:49
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-38599 Aquestive Therapeutics, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 30 Technolog ...